Search
News & Events
Why tiny dust mites are a big problemThe molecular studies of Professor Wayne Thomas, particularly on house dust mites, have provided new understandings of allergy and new diagnostics.
News & Events
Study finds IVF twins have more health problemsTwins born as a result of assisted reproductive technology (ART) such as IVF are more likely to be admitted to neonatal intensive care
News & Events
Landmark study halves skin infections in remote Aboriginal kidsLed by The Kids Research Institute Australia and Aboriginal health organisations in close partnership with nine Aboriginal communities in Western Australia’s Kimberley region, the five-year SToP Trial set out to identify the best possible methods to See, Treat and Prevent painful skin sores and scabies.
News & Events
New Stan Perron Charitable Foundation grants to accelerate WA child health researchFunding from the Stan Perron Charitable Foundation will support world class researchers at The Kids Research Institute Australia to improve the health and wellbeing of WA children facing serious health challenges.
News & Events
Fresh Science to target painful ear infectionsThe Kids's Dr Ruth Thornton is one of 12 finalists in the annual national Fresh Science competition with her research into middle-ear infections.
News & Events
Perth’s Aboriginal babies show first signs of ear disease at just eight weeksThe Kids Research Institute Australia researchers have found close to 40 per cent of Aboriginal babies begin to develop middle ear infections between two and four months of age in a first of its kind study in metropolitan Perth.
People
Associate Professor Lea-Ann KirkhamCo-Head, Bacterial Respiratory Infectious Disease Group; Microbiology Lead, Wesfarmers Centre of Vaccines & Infectious Diseases
Research
Unlocking the immunology of whooping cough vaccines to guide the development of improved vaccines and schedules in AustraliaRuth Peter Thornton Richmond PhD MBBS MRCP(UK) FRACP Co-head, Bacterial Respiratory Infectious Disease Group (BRIDG) Head, Vaccine Trials Group
News & Events
New drug therapy provides hope for kids with cystic fibrosisThe family of two girls with cystic fibrosis are hopeful after The Kids Research Institute Australia spin-off company, Respirion, receives $20 million in funding to develop a promising new therapy.